Topokine Therapeutics, Inc.
7 clinical trials · Sponsor
◉ Watch Topokine Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags) (NCT02607683) | Topokine Therapeutics, Inc. | 2016-01-01 |
| Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds (NCT02607670) | Topokine Therapeutics, Inc. | 2016-01-01 |
| Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale (NCT02609763) | Topokine Therapeutics, Inc. | 2015-11-01 |
| Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers (NCT02647853) | Topokine Therapeutics, Inc. | 2014-10-01 |
| Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) (NCT02230761) | Topokine Therapeutics, Inc. | 2014-09-01 |
| Safety and Feasibility Study of XAF5 Gel for Reduction of Submental Fat (NCT01990326) | Topokine Therapeutics, Inc. | 2013-11-01 |
| Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers (NCT01723241) | Topokine Therapeutics, Inc. | 2012-11-01 |
Track Topokine Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.